Dr Reddy's Lab launches OTC store-brand equivalent of Mucinex D Extended Release Tablets
9th Jul 2019

Dr. Reddy's Laboratories has launched an over-the-counter (OTC) store-brand equivalent of Mucinex D Extended Release Tablets in two strengths-Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg, and Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg-in the United States market, as approved by the US Food and Drug Administration (USFDA).

The company’s OTC Guaifenesin and Pseudoephedrine HCI is used to help loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive; temporarily relieve nasal congestion due to common cold, hay fever, and upper respiratory allergies; temporarily restore freer breathing through the nose; promote nasal and/or sinus drainage; and temporarily relieve sinus congestion and pressure.

According to IRI, the Mucinex D brand and store brands had combined US sales of around $71 million MAT for the most recent twelve months ending in May 2019. The company’s OTC Guaifenesin 1200 mg and Pseudoephedrine HCI 120 mg is available in 24-count packages. Also, the company’s OTC Guaifenesin 600 mg and Pseudoephedrine HCI 60 mg is available in 18 and 36-count packages. 

Dr. Reddy's Laboratories is a multinational pharmaceutical company based in Hyderabad, Telangana in India. It manufactures and markets a wide range of pharmaceuticals in India and overseas.